Opinion|Videos|December 22, 2025

Current Treatment Guidelines for Schizophrenia

Panelists discuss how evidence-based, patient-tailored guideline adherence enhances long-term schizophrenia outcomes.

Panelists discuss how the latest APA guidelines advocate a multimodal approach combining pharmacologic treatment with psychosocial interventions such as cognitive-behavioral therapy and supported employment.

Panelists discuss how adherence, monitoring of adverse effects, and collaborative care are emphasized as pillars of sustained stability. Clinicians are encouraged to adapt evidence-based strategies to individual patient profiles.

Panelists discuss how guideline adherence improves outcomes, but flexibility is required to tailor interventions to patients’ unique needs, comorbidities, and cultural contexts.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo